VCM
STJ

Vigilant Capital Management’s St Jude Medical STJ Stock Holding History

Vigilant Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-103
Closed -$8K – 392
2016
Q2 		$8K Buy
+103
New +$7.34K ﹤0.01% 295

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vigilant Capital Management's STJ Position: Q3 2016 in Review

Vigilant Capital Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 103 shares — an estimated $8K sold.

Vigilant Capital Management first reported a position in STJ in Q2 2016 and held it in 1 quarter. The position peaked at $8K in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Vigilant Capital Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Vigilant Capital Management sold 103 St Jude Medical shares in Q3 2016, an estimated $8K.
  • Vigilant Capital Management first reported a position in St Jude Medical in Q2 2016 and held it in 1 quarter.
  • Vigilant Capital Management's St Jude Medical position peaked at $8K in Q2 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Vigilant Capital Management's 13F filing for Q3 2016, filed 14 Oct 2016.